MoCRA does not require you to submit safety data directly to the FDA at the time of product listing, but it does require that you have documented safety substantiation available and can produce it upon FDA request. This is a critical distinction: the FDA does not have a central database of all cosmetic safety studies, but the agency expects you to retain a safety file and provide it during an inspection or in response to a warning letter. If you cannot produce the safety substantiation when asked, your product can be deemed adulterated or misbranded.
The core of your safety file is a cosmetic safety assessment (CSA), also called a cosmetic product safety file. This is typically a 20–50 page document prepared by a qualified cosmetic chemist or toxicologist that includes: a description of the product and its intended use, a complete ingredient list with INCI names and concentrations, a hazard assessment of each ingredient (toxicity profile, concentration thresholds of concern, regulatory status in other regions), an assessment of the formula's safety under conditions of use (considering age group, frequency of application, skin type, body area where applied), review of any stability or compatibility issues, and a conclusion that the product is safe. For leave-on products applied to sensitive skin or used on children, the CSA is more rigorous. For rinse-off products (shampoos, body washes), the bar is typically lower because exposure is limited.
You do not always need to conduct costly third-party testing to have a defensible CSA. Many smaller brands rely on a literature-based safety assessment: your chemist reviews published studies on each ingredient, consults toxicology databases (like HSDB or PubChem), and compares the concentration in your formula to the no-effect level documented in the literature. If your lavender fragrance is used at 0.5% and published data shows lavender oil is safe at concentrations up to 5%, your chemist can justify safety without additional testing. However, if an ingredient is novel, used at an unusually high concentration, or combined with other actives in a way that hasn't been studied, your chemist will likely recommend stability testing or microbiological testing to fill that gap.
Stability testing data strengthens your safety file. Stability testing assesses whether a formula degrades, separates, discolors, or develops microbial growth over time. A common protocol (though not a legal requirement — the right protocol depends on your product and market) involves storing samples at 40 °C and 75% relative humidity for 8–12 weeks, then testing them for appearance, odor, viscosity, pH, and microbial load. Real-time stability testing at room temperature for 6–12 months is more rigorous but takes longer. If your product is supposed to last 12 months on a shelf, you need data or justification showing it won't degrade or become contaminated during that period. Without stability data, the FDA may question how you can claim the product is safe for the entire shelf life you're listing.
Microbiological testing is often required or strongly recommended for water-containing cosmetics (creams, lotions, serums). The test checks for bacterial and fungal contamination. USP or pharmacopeial standards (typically <100 CFU/g for aerobic bacteria, <10 CFU/g for molds and yeasts) are common thresholds, but the specific limits should be justified based on product type and intended use. If your product is preservative-free and water-based, expect higher scrutiny and potentially higher microbiological limits if you can justify them with published literature.
Due diligence on raw material safety is also part of the file. You should maintain Certificates of Analysis (CoAs) from your ingredient suppliers showing that each raw material meets its specification and is free of harmful contaminants. If you're using botanical extracts or essential oils, CoAs confirming the botanical identity and purity add credibility. If an ingredient has been flagged by regulatory bodies (e.g., the EU has restricted or banned it), your file should document why it's safe for use in the US or why it doesn't apply to your formula.
Several FDA guidance documents outline expectations for safety data, particularly the 2016 guidance on cosmetic safety assessment (before MoCRA) and the 2023 MoCRA implementation guidance. Both emphasize that safety assessment is a science-based, risk-proportionate process — you invest more in data for products with higher risk (leave-on, sensitive populations) and less for lower-risk products (rinse-off, adult use). An approved chemist on AJ Cosmo Labs can help you determine what level of safety substantiation your specific product actually needs and to prepare a defensible file that won't trigger FDA concerns during inspection.
Read the full guide on FDA MoCRA Requirements Before Selling Cosmetics in the US →